BAM
BLFS icon

Belpointe Asset Management’s BioLife Solutions BLFS Stock Holding History

Belpointe Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-199
Closed -$4.33K – 906
2023
Q1 		$4.33K Hold
199
– – ﹤0.01% 3069
2022
Q4 		$3.62K Buy
+199
New +$4.11K ﹤0.01% 3042

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Belpointe Asset Management's BLFS Position: Q2 2023 in Review

Belpointe Asset Management sold out of BioLife Solutions (BLFS) in Q2 2023, closing a stake of 199 shares — an estimated $4.33K sold.

Belpointe Asset Management first reported a position in BLFS in Q4 2022 and held it in 2 quarters. The position peaked at $4.33K in Q1 2023. 156 funds tracked by Wall St. Rank hold BLFS as of Q2 2023.

  • Belpointe Asset Management reported no remaining BioLife Solutions position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 199 BioLife Solutions shares in Q2 2023, an estimated $4.33K.
  • Belpointe Asset Management first reported a position in BioLife Solutions in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's BioLife Solutions position peaked at $4.33K in Q1 2023.
  • 156 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.